Literature DB >> 9109901

Rapid-onset dystonia-parkinsonism in a second family.

A Brashear1, D DeLeon, S B Bressman, D Thyagarajan, M R Farlow, W B Dobyns.   

Abstract

Rapid-onset dystonia-parkinsonism (RDP), first described in a large Midwestern family, is now reported in a second, apparently unrelated, family in which four individuals have this same syndrome. All four developed sudden onset of dysarthria, dysphagia, severe dystonic spasms, bradykinesia, and postural instability over less than 1 hour to a few days. Three of the four had stable limb dystonia for several years preceding the onset of combined dystonia-parkinsonism. Treatment with levodopa/carbidopa provided little benefit. We propose diagnostic criteria for RDP and further define the spectrum of this unusual disease.

Entities:  

Mesh:

Year:  1997        PMID: 9109901     DOI: 10.1212/wnl.48.4.1066

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism.

Authors:  Richard L Barbano; Deborah F Hill; Beverly M Snively; Laney S Light; Niki Boggs; W Vaughn McCall; Mark Stacy; Laurie Ozelius; Kathleen J Sweadner; Allison Brashear
Journal:  Parkinsonism Relat Disord       Date:  2012-04-24       Impact factor: 4.891

Review 2.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

3.  Mosaicism in ATP1A3-related disorders: not just a theoretical risk.

Authors:  Marie Hully; Juliette Ropars; Laurence Hubert; Nathalie Boddaert; Marlene Rio; Mathieu Bernardelli; Isabelle Desguerre; Valerie Cormier-Daire; Arnold Munnich; Pascale de Lonlay; Louise Reilly; Claude Besmond; Nadia Bahi-Buisson
Journal:  Neurogenetics       Date:  2016-10-10       Impact factor: 2.660

4.  Psychiatric disorders in rapid-onset dystonia-parkinsonism.

Authors:  Allison Brashear; Jared F Cook; Deborah F Hill; Alethea Amponsah; Beverly M Snively; Laney Light; Niki Boggs; Cynthia K Suerken; Mark Stacy; Laurie Ozelius; Kathleen J Sweadner; W Vaughn McCall
Journal:  Neurology       Date:  2012-08-29       Impact factor: 9.910

5.  α3Na+/K+-ATPase deficiency causes brain ventricle dilation and abrupt embryonic motility in zebrafish.

Authors:  Canan Doğanli; Hans C Beck; Angeles B Ribera; Claus Oxvig; Karin Lykke-Hartmann
Journal:  J Biol Chem       Date:  2013-02-11       Impact factor: 5.157

6.  Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism.

Authors:  Mark P DeAndrade; Fumiaki Yokoi; Thomas van Groen; Jerry B Lingrel; Yuqing Li
Journal:  Behav Brain Res       Date:  2010-09-17       Impact factor: 3.332

Review 7.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

8.  Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly.

Authors:  Alex R Paciorkowski; Sharon S McDaniel; Laura A Jansen; Hannah Tully; Emily Tuttle; Dalia H Ghoneim; Srinivasan Tupal; Sonya A Gunter; Valeria Vasta; Qing Zhang; Thao Tran; Yi B Liu; Laurie J Ozelius; Allison Brashear; Kathleen J Sweadner; William B Dobyns; Sihoun Hahn
Journal:  Epilepsia       Date:  2015-02-05       Impact factor: 5.864

Review 9.  ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia.

Authors:  Allison Brashear; Jonathan W Mink; Deborah F Hill; Niki Boggs; W Vaughn McCall; Mark A Stacy; Beverly Snively; Laney S Light; Kathleen J Sweadner; Laurie J Ozelius; Leslie Morrison
Journal:  Dev Med Child Neurol       Date:  2012-08-28       Impact factor: 5.449

Review 10.  Distinct neurological disorders with ATP1A3 mutations.

Authors:  Erin L Heinzen; Alexis Arzimanoglou; Allison Brashear; Steven J Clapcote; Fiorella Gurrieri; David B Goldstein; Sigurður H Jóhannesson; Mohamad A Mikati; Brian Neville; Sophie Nicole; Laurie J Ozelius; Hanne Poulsen; Tsveta Schyns; Kathleen J Sweadner; Arn van den Maagdenberg; Bente Vilsen
Journal:  Lancet Neurol       Date:  2014-05       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.